Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

107
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
107
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

240
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
240
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

278
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
278
Traumatic Memory01:20

Traumatic Memory

169
Emotionally traumatic events often lead to memories that are exceptionally vivid and enduring, sometimes persisting with remarkable clarity throughout an individual's life. A classic example of this phenomenon is a person who survives a car accident. Even years later, they may recall every detail of the event with startling accuracy — the screeching of the tires, the jarring impact, and the acrid smell of burning rubber. Such vividness contrasts sharply with how an individual...
169
Dissociative Disorders01:27

Dissociative Disorders

180
Dissociative disorders represent complex psychological conditions characterized by disruptions in consciousness, memory, identity, or perception. These disruptions cause individuals to experience a disconnection from their thoughts, emotions, and memories. The phenomenon is not merely an occasional lapse in attention but a profound alteration in mental functioning that can severely impact daily life.
Dissociative Fugue
A hallmark feature of dissociative disorders is the dissociative fugue...
180
Psychosurgery01:30

Psychosurgery

102
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
102

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-specific associations of depression with inflammatory markers: a systematic review and meta-analysis.

Translational psychiatry·2026
Same author

Inflammatory markers in the emergency department and PTSD symptoms in the AURORA Study: A longitudinal cohort study.

Psychological medicine·2026
Same author

Development of a mandarin version of the five dimensional altered states of consciousness (5D-ASC) rating scale.

Drug science, policy and law·2026
Same author

Bigger But Not Better: Small Neural Language Models Outperform Large Language Models in Detection of Thought Disorder.

... Workshop on Computational Linguistics and Clinical Psychology·2025
Same author

Associations of lifetime stressors and health behaviors with inflammation in young adults previously placed in youth residential care.

Brain, behavior, & immunity - health·2025
Same author

The allostatic triage model of psychopathology (ATP Model): How reallocation of brain energetic resources under stress elicits psychiatric symptoms.

Neuroscience and biobehavioral reviews·2025

Related Experiment Video

Updated: Sep 7, 2025

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.1K

Psilocybin for Trauma-Related Disorders.

Amanda J Khan1, Ellen Bradley1, Aoife O'Donovan1

  • 1Department of Psychiatry, University of California, San Francisco, CA, USA.

Current Topics in Behavioral Neurosciences
|June 17, 2022
PubMed
Summary

Psilocybin-assisted psychotherapy shows promise for treating posttraumatic stress disorder (PTSD). This innovative approach may help individuals confront trauma and improve mental health outcomes.

Keywords:
Posttraumtic Stress DisorderPsilocybinPsychedelicsTraumaTreatment

More Related Videos

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder
09:55

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder

Published on: March 8, 2018

12.7K
How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression
07:00

How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression

Published on: January 23, 2017

24.3K

Related Experiment Videos

Last Updated: Sep 7, 2025

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.1K
Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder
09:55

Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder

Published on: March 8, 2018

12.7K
How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression
07:00

How to Use the H1 Deep Transcranial Magnetic Stimulation Coil for Conditions Other than Depression

Published on: January 23, 2017

24.3K

Area of Science:

  • Psychiatry and Neuroscience
  • Pharmacology
  • Psychotherapy Research

Background:

  • Posttraumatic stress disorder (PTSD) is a chronic mental health condition with limited treatment efficacy.
  • There is a pressing need for novel therapeutic strategies to address PTSD.
  • Converging evidence suggests the potential of psilocybin in treating trauma-related disorders.

Purpose of the Study:

  • To review the existing literature on the therapeutic potential of psilocybin for PTSD.
  • To explore the preliminary findings of psilocybin-assisted psychotherapy (PAP) in related conditions.
  • To highlight the need for further research into PAP for PTSD.

Main Methods:

  • Literature review of studies investigating psilocybin and related compounds for trauma and PTSD.
  • Analysis of an open-label study involving traumatized AIDS survivors treated with PAP.
  • Examination of preliminary data from PAP trials for conditions relevant to PTSD recovery.

Main Results:

  • An open-label study indicated PAP reduced PTSD symptoms, attachment anxiety, and demoralization in traumatized individuals.
  • Preliminary PAP trials suggest efficacy in facilitating trauma memory confrontation, reducing emotional avoidance, and improving self-compassion.
  • Early evidence indicates classic psychedelics may significantly reduce PTSD symptoms in combat veterans.

Conclusions:

  • Psilocybin-assisted psychotherapy (PAP) demonstrates preliminary efficacy and warrants further investigation as a novel treatment for PTSD.
  • PAP may facilitate key aspects of PTSD recovery, including confronting trauma and increasing self-compassion.
  • While promising, the field requires more research to understand mechanisms and risks associated with psychedelic therapy for PTSD.